Adjuvant for Vaccine Immunotherapy of Cancer - Focusing on Toll-Like Receptor 2 and 3 Agonists for Safely Enhancing Antitumor Immunity
Cancer Science - United States
doi 10.1111/cas.12824
Full Text
Open PDFAbstract
Available in full text
Date
November 18, 2015
Authors
Publisher
Wiley